Loading...

Loading...

Cumberland Pharmaceuticals Reports 12% Revenue Growth in 2025
By MBN Staff - Wed, 11/05/2025 - 17:52
Cumberland Pharmaceuticals reports 12% year-to-date revenue growth, driven by new partnerships and international expansion.

Partnership Content

Cluster Automotriz Nuevo Leon
https://mexicobusiness.news/tag/cumberland-pharmaceuticals
More Health
FDA Grants Ifetroban Orphan Drug Status
By MBN Staff - Thu, 11/07/2024 - 09:38
The US Food and Drug Administration granted Cumberland Pharmaceuticals' Ifetroban Orphan Drug and Rare Pediatric Disease designations.